Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement.
Dietz MS, Al-Ibraheemi A, Davis JL, Hawkins CM, Craig BT, Dasgupta R, Geller DS, Shulman DS, Cohen-Gogo S, Gupta A, Whiteway SL, Slotkin EK, Heske CM, Ahmed SK, Indelicato DJ, Albert CM, Montgomery N, Sandberg JK, Grier HE, Krailo M, Isakoff MS, Rubin E, Lawlor ER, DuBois SG, Mascarenhas L, Grohar PJ, Binitie O, Reed D, Janeway K, Roberts RD, Bailey KM. Dietz MS, et al. Among authors: heske cm. J Natl Compr Canc Netw. 2024 Dec 27;23(1):e247063. doi: 10.6004/jnccn.2024.7063. J Natl Compr Canc Netw. 2024. PMID: 39729709
Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical Trial.
Bisogno G, Minard-Colin V, Haduong J, Zanetti I, Ferrari A, Chisholm J, Heske CM, Hladun R, Jenney M, Merks JHM, Venkatramani R. Bisogno G, et al. Among authors: heske cm. Pediatr Blood Cancer. 2025 Feb;72(2):e31436. doi: 10.1002/pbc.31436. Epub 2024 Nov 20. Pediatr Blood Cancer. 2025. PMID: 39568171
Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response.
Lee U, Szabova L, Collins VJ, Gordon M, Johnson K, Householder D, Jorgensen S, Lu L, Bassel L, Elloumi F, Peer CJ, Nelson AE, Varriano S, Varma S, Roberts RD, Ohler ZW, Figg WD, Sharan SK, Pommier Y, Heske CM. Lee U, et al. Among authors: heske cm. Front Cell Dev Biol. 2024 Oct 24;12:1462840. doi: 10.3389/fcell.2024.1462840. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39512899 Free PMC article.
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the novel NAMPT Inhibitor OT-82.
Najera SS, Ricketts CJ, Schmidt LS, Medina JI, Saito K, Ileva L, Brender JR, James AM, Peer CJ, Gouker B, Karim BO, Chernova O, Wells C, Wei MH, Yang Y, Zhang X, Klumpp-Thomas C, Travers J, Chen L, Wilson KM, Issaq SH, Figg WD, Difilippantonio S, Kalen JD, Krishna MC, Thomas CJ, Ceribelli M, Heske CM, Crooks DR, Meier JL. Najera SS, et al. Among authors: heske cm. Mol Cancer Ther. 2024 Oct 14. doi: 10.1158/1535-7163.MCT-24-0225. Online ahead of print. Mol Cancer Ther. 2024. PMID: 39397296
Valence-band hybridization in sulphides.
Weinhardt L, Hauschild D, Wansorra C, Steininger R, Blum M, Yang W, Heske C. Weinhardt L, et al. Among authors: heske c. Phys Chem Chem Phys. 2024 Oct 23;26(41):26389-26397. doi: 10.1039/d4cp02894e. Phys Chem Chem Phys. 2024. PMID: 39387819 Free article.
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.
Metts JL, Aye JM, Crane JN, Oberoi S, Balis FM, Bhatia S, Bona K, Carleton B, Dasgupta R, Dela Cruz FS, Greenzang KA, Kaufman JL, Linardic CM, Parsons SK, Robertson-Tessi M, Rudzinski ER, Soragni A, Stewart E, Weigel BJ, Wolden SL, Weiss AR, Venkatramani R, Heske CM. Metts JL, et al. Among authors: heske cm. Cancer. 2024 Nov 15;130(22):3785-3796. doi: 10.1002/cncr.35457. Epub 2024 Jun 28. Cancer. 2024. PMID: 38941509
88 results